Trial Profile
Effect of Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study): a Randomized Study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary)
- Indications Fibrosis; Inflammation; Proteinuria
- Focus Therapeutic Use
- Acronyms PALIFE Study
- 29 Apr 2015 New trial record